The Supreme Court's (re)consideration of the enablement requirement expected in its decision later this year in Amgen v. Sanofi may be the most closely watched patent case since AMP v..
Inventions with numerical ranges are valuable across different technologies. Obtaining claims with numerical ranges provide competitive advantages to patent owners. Frequently, a.
Cerus Endovascular Announces the First Ever Robotic Assist Intracranial Implant of its Contour Intrasaccular Device
Groundbreaking Aneurysm Procedure Completed in 28 Minutes
News provided by
Share this article
Share this article
FREMONT, Calif. and OXFORD, United Kingdom, Dec. 17, 2020 /PRNewswire/ Cerus Endovascular Ltd., a privately-held, commercial stage medical device company, today announced the first ever robotically assisted intracranial implant of its Contour intrasaccular device. The groundbreaking procedure was completed at the King Edward Memorial Hospital, Mumbai, by renowned neurosurgeon, Dr. Nitin Dange and was performed on a Middle Cerebral Aneurysm with a 7mm Contour device. Procedural time, including access and placement of the Contour, took a total of 28 minutes.